Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of THR-18 with tPA in Acute Ischemic Stroke
NCT02572336Phase 2Unknown
- Sponsor
- D-Pharm
- Start
- Oct 2015
- Primary completion
- Mar 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute ischemic stroke (AIS) comparing THR-18 + tPA with Placebo + tPA (2 arms). Primary endpoints: Physical examination at 30 days, ASPECTS score at 2 days and 10 more. Status: unknown.
02
Drugs
THR-18
03
Conditions
acute ischemic stroke (AIS)
Beyond the preview
Go deeper on NCT02572336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02572336.